PNJ [OUTPERFORM +13.6%] - Bright growth outlook as COVID-19 disruptions ease

We downgrade our rating from BUY to OUTPERFORM as PNJ’s share price has risen 4% in the last 2.5 months. Furthermore, we curtail our target price (TP) by 2%.